These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions. Robertson LE; Keating MJ Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874 [No Abstract] [Full Text] [Related]
23. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma]. Arima N; Mizoguchi H; Shirakawa S; Tomonaga M; Takatsuki K; Ohno R Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292 [TBL] [Abstract][Full Text] [Related]
24. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. Keating MJ; O'Brien S; Albitar M; Lerner S; Plunkett W; Giles F; Andreeff M; Cortes J; Faderl S; Thomas D; Koller C; Wierda W; Detry MA; Lynn A; Kantarjian H J Clin Oncol; 2005 Jun; 23(18):4079-88. PubMed ID: 15767648 [TBL] [Abstract][Full Text] [Related]
25. [Fludarabine monophosphate in the treatment of patients with advanced stages of chronic B-cell lymphatic leukemia resistant to conventional chemotherapy]. Papajík T; Faber E; Hubácek J; Slezák P; Raida L; Heczko M; Sulovská I; Jarosová M; Pikalová Z; Indrák K Vnitr Lek; 1997 Jan; 43(1):25-8. PubMed ID: 9221561 [TBL] [Abstract][Full Text] [Related]
26. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. Byrd JC; Peterson B; Piro L; Saven A; Vardiman JW; Larson RA; Schiffer C Leukemia; 2003 Feb; 17(2):323-7. PubMed ID: 12592330 [TBL] [Abstract][Full Text] [Related]
27. Tumor lysis syndrome induced by fludarabine monophosphate: a case report. Nakhoul F; Green J; Abassi ZA; Carter A Eur J Haematol; 1996 Apr; 56(4):254-5. PubMed ID: 8641396 [No Abstract] [Full Text] [Related]
28. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia. Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691 [TBL] [Abstract][Full Text] [Related]
29. High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia. Cazin B; Divine M; Leprêtre S; Travade P; Tournilhac O; Delmer A; Jaubert J; Feugier P; Dreyfus B; Mahé B; Grosbois B; Maloisel F; Eghbali H; Dumontet C; Bénichou J; Guibon O; Leleu X; Leporrier M; Maloum K Br J Haematol; 2008 Oct; 143(1):54-9. PubMed ID: 18710390 [TBL] [Abstract][Full Text] [Related]
30. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy]. Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967 [TBL] [Abstract][Full Text] [Related]
31. Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia. Tóthová E; Kafková A; Fricová M; Guman T; Stecová N Neoplasma; 2003; 50(6):433-7. PubMed ID: 14689065 [TBL] [Abstract][Full Text] [Related]
32. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia. Schilling PJ; Vadhan-Raj S N Engl J Med; 1990 Sep; 323(12):833-4. PubMed ID: 1697401 [No Abstract] [Full Text] [Related]
33. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL. Binet JL Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518 [TBL] [Abstract][Full Text] [Related]